Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022

Upgrades

Northcoast Research upgraded the previous rating for SpartanNash Co SPTN from Neutral to Buy. SpartanNash earned $0.55 in the third quarter, compared to $0.43 in the year-ago quarter. The current stock performance of SpartanNash shows a 52-week-high of $37.75 and a 52-week-low of $23.74. Moreover, at the end of the last trading period, the closing price was at $32.85.

For Regions Financial Corp RF, Wolfe Research upgraded the previous rating of Peer Perform to Outperform. In the third quarter, Regions Financial showed an EPS of $0.56, compared to $0.66 from the year-ago quarter. At the moment, the stock has a 52-week-high of $25.57 and a 52-week-low of $18.01. Regions Financial closed at $23.21 at the end of the last trading period.

According to Morgan Stanley, the prior rating for Tencent Music Entertainment Group TME was changed from Equal-Weight to Overweight. Tencent Music Enter Gr earned $0.12 in the third quarter, compared to $0.09 in the year-ago quarter. The current stock performance of Tencent Music Enter Gr shows a 52-week-high of $7.66 and a 52-week-low of $2.95. Moreover, at the end of the last trading period, the closing price was at $7.01.

According to Wells Fargo, the prior rating for Lennox International Inc LII was changed from Equal-Weight to Overweight. For the third quarter, Lennox International had an EPS of $4.10, compared to year-ago quarter EPS of $3.40. At the moment, the stock has a 52-week-high of $334.78 and a 52-week-low of $182.85. Lennox International closed at $260.43 at the end of the last trading period.

According to Wolfe Research, the prior rating for Vertiv Holdings Co VRT was changed from Peer Perform to Outperform. For the third quarter, Vertiv Holdings had an EPS of $0.23, compared to year-ago quarter EPS of $0.20. The current stock performance of Vertiv Holdings shows a 52-week-high of $27.04 and a 52-week-low of $7.76. Moreover, at the end of the last trading period, the closing price was at $13.85.

Morgan Stanley upgraded the previous rating for Navient Corp NAVI from Underweight to Equal-Weight. For the third quarter, Navient had an EPS of $0.75, compared to year-ago quarter EPS of $0.92. The stock has a 52-week-high of $22.59 and a 52-week-low of $12.45. At the end of the last trading period, Navient closed at $16.57.

For Pentair PLC PNR, Barclays upgraded the previous rating of Equal-Weight to Overweight. In the third quarter, Pentair showed an EPS of $0.99, compared to $0.89 from the year-ago quarter. At the moment, the stock has a 52-week-high of $76.78 and a 52-week-low of $38.55. Pentair closed at $45.77 at the end of the last trading period.

According to Goldman Sachs, the prior rating for BioXcel Therapeutics Inc BTAI was changed from Sell to Neutral. In the third quarter, BioXcel Therapeutics showed an EPS of $1.49, compared to $0.96 from the year-ago quarter. The current stock performance of BioXcel Therapeutics shows a 52-week-high of $24.57 and a 52-week-low of $8.79. Moreover, at the end of the last trading period, the closing price was at $16.57.

For StoneCo Ltd STNE, Goldman Sachs upgraded the previous rating of Sell to Neutral. StoneCo earned $0.10 in the third quarter, compared to $0.09 in the year-ago quarter. The stock has a 52-week-high of $19.66 and a 52-week-low of $6.81. At the end of the last trading period, StoneCo closed at $11.68.

See all analyst ratings upgrades.

Downgrades

According to CL King, the prior rating for G-III Apparel Group Ltd GIII was changed from Buy to Neutral. In the third quarter, G-III Apparel Group showed an EPS of $1.35, compared to $2.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $32.76 and a 52-week-low of $14.37. G-III Apparel Group closed at $21.63 at the end of the last trading period.

According to Lake Street, the prior rating for OncoCyte Corp OCX was changed from Buy to Hold. At the moment, the stock has a 52-week-high of $2.68 and a 52-week-low of $0.35. OncoCyte closed at $0.47 at the end of the last trading period.

For Lufax Holding Ltd LU, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. For the third quarter, Lufax Holding had an EPS of $0.08, compared to year-ago quarter EPS of $0.26. The stock has a 52-week-high of $7.05 and a 52-week-low of $1.26. At the end of the last trading period, Lufax Holding closed at $1.86.

Stifel downgraded the previous rating for Leslies Inc LESL from Buy to Hold. For the fourth quarter, Leslies had an EPS of $0.35, compared to year-ago quarter EPS of $0.26. The stock has a 52-week-high of $24.40 and a 52-week-low of $12.79. At the end of the last trading period, Leslies closed at $14.60.

According to JP Morgan, the prior rating for Liberty Global PLC LBTYA was changed from Overweight to Neutral. For the third quarter, Liberty Global had an EPS of $4.87, compared to year-ago quarter EPS of $0.48. The current stock performance of Liberty Global shows a 52-week-high of $29.08 and a 52-week-low of $15.22. Moreover, at the end of the last trading period, the closing price was at $20.08.

For G-III Apparel Group Ltd GIII, Piper Sandler downgraded the previous rating of Overweight to Neutral. G-III Apparel Group earned $1.35 in the third quarter, compared to $2.16 in the year-ago quarter. The current stock performance of G-III Apparel Group shows a 52-week-high of $32.76 and a 52-week-low of $14.37. Moreover, at the end of the last trading period, the closing price was at $21.63.

According to Consumer Edge Research, the prior rating for B&G Foods Inc BGS was changed from Equal-Weight to Underweight. For the third quarter, B&G Foods had an EPS of $0.31, compared to year-ago quarter EPS of $0.55. The current stock performance of B&G Foods shows a 52-week-high of $34.27 and a 52-week-low of $12.29. Moreover, at the end of the last trading period, the closing price was at $13.28.

Guggenheim downgraded the previous rating for ONE Gas Inc OGS from Neutral to Sell. ONE Gas earned $0.44 in the third quarter, compared to $0.38 in the year-ago quarter. The current stock performance of ONE Gas shows a 52-week-high of $92.26 and a 52-week-low of $64.37. Moreover, at the end of the last trading period, the closing price was at $86.95.

For U.S. Bancorp USB, Wolfe Research downgraded the previous rating of Outperform to Peer Perform. For the third quarter, U.S. Bancorp had an EPS of $1.18, compared to year-ago quarter EPS of $1.30. The current stock performance of U.S. Bancorp shows a 52-week-high of $63.57 and a 52-week-low of $38.39. Moreover, at the end of the last trading period, the closing price was at $45.39.

B of A Securities downgraded the previous rating for Parsons Corp PSN from Neutral to Underperform. In the third quarter, Parsons Corp showed an EPS of $0.48, compared to $0.44 from the year-ago quarter. The current stock performance of Parsons Corp shows a 52-week-high of $50.15 and a 52-week-low of $29.25. Moreover, at the end of the last trading period, the closing price was at $49.50.

According to B of A Securities, the prior rating for SQZ Biotechnologies Co SQZ was changed from Buy to Underperform. In the third quarter, SQZ Biotechnologies showed an EPS of $0.77, compared to $0.80 from the year-ago quarter. The stock has a 52-week-high of $13.53 and a 52-week-low of $2.00. At the end of the last trading period, SQZ Biotechnologies closed at $2.51.

According to Wolfe Research, the prior rating for Zebra Technologies Corp ZBRA was changed from Peer Perform to Underperform. For the third quarter, Zebra Technologies had an EPS of $4.12, compared to year-ago quarter EPS of $4.55. At the moment, the stock has a 52-week-high of $615.00 and a 52-week-low of $224.87. Zebra Technologies closed at $270.28 at the end of the last trading period.

B of A Securities downgraded the previous rating for Saia Inc SAIA from Neutral to Underperform. For the third quarter, Saia had an EPS of $3.67, compared to year-ago quarter EPS of $2.86. The current stock performance of Saia shows a 52-week-high of $344.44 and a 52-week-low of $168.03. Moreover, at the end of the last trading period, the closing price was at $243.59.

According to Wolfe Research, the prior rating for Vontier Corp VNT was changed from Outperform to Peer Perform. In the third quarter, Vontier showed an EPS of $0.86, compared to $0.80 from the year-ago quarter. At the moment, the stock has a 52-week-high of $32.31 and a 52-week-low of $16.55. Vontier closed at $19.63 at the end of the last trading period.

For Regal Rexnord Corp RRX, Wolfe Research downgraded the previous rating of Outperform to Peer Perform. For the third quarter, Regal Rexnord had an EPS of $2.66, compared to year-ago quarter EPS of $2.36. The current stock performance of Regal Rexnord shows a 52-week-high of $176.91 and a 52-week-low of $108.28. Moreover, at the end of the last trading period, the closing price was at $131.11.

Citigroup downgraded the previous rating for Sirius XM Holdings Inc SIRI from Buy to Sell. For the third quarter, Sirius XM Holdings had an EPS of $0.07, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $6.88 and a 52-week-low of $5.69. At the end of the last trading period, Sirius XM Holdings closed at $6.49.

According to Wolfe Research, the prior rating for Hubbell Inc HUBB was changed from Peer Perform to Underperform. Hubbell earned $3.08 in the third quarter, compared to $2.24 in the year-ago quarter. The current stock performance of Hubbell shows a 52-week-high of $261.58 and a 52-week-low of $170.21. Moreover, at the end of the last trading period, the closing price was at $254.06.

According to Wolfe Research, the prior rating for CrowdStrike Holdings Inc CRWD was changed from Outperform to Peer Perform. In the third quarter, CrowdStrike Holdings showed an EPS of $0.40, compared to $0.17 from the year-ago quarter. The current stock performance of CrowdStrike Holdings shows a 52-week-high of $242.00 and a 52-week-low of $108.89. Moreover, at the end of the last trading period, the closing price was at $117.65.

JP Morgan downgraded the previous rating for Victoria's Secret & Co VSCO from Overweight to Neutral. For the third quarter, Victoria's Secret had an EPS of $0.29, compared to year-ago quarter EPS of $0.81. The current stock performance of Victoria's Secret shows a 52-week-high of $65.20 and a 52-week-low of $26.14. Moreover, at the end of the last trading period, the closing price was at $46.00.

According to Morgan Stanley, the prior rating for Ally Financial Inc ALLY was changed from Equal-Weight to Underweight. For the third quarter, Ally Financial had an EPS of $1.12, compared to year-ago quarter EPS of $2.16. At the moment, the stock has a 52-week-high of $53.83 and a 52-week-low of $24.83. Ally Financial closed at $27.01 at the end of the last trading period.

According to Morgan Stanley, the prior rating for Synchrony Financial SYF was changed from Equal-Weight to Underweight. For the third quarter, Synchrony Finl had an EPS of $1.47, compared to year-ago quarter EPS of $2.00. At the moment, the stock has a 52-week-high of $50.20 and a 52-week-low of $27.21. Synchrony Finl closed at $37.58 at the end of the last trading period.

For Capital One Financial Corp COF, Morgan Stanley downgraded the previous rating of Equal-Weight to Underweight. Capital One Financial earned $4.20 in the third quarter, compared to $6.86 in the year-ago quarter. At the moment, the stock has a 52-week-high of $162.40 and a 52-week-low of $90.27. Capital One Financial closed at $103.24 at the end of the last trading period.

Barclays downgraded the previous rating for Otis Worldwide Corp OTIS from Overweight to Equal-Weight. Otis Worldwide earned $0.80 in the third quarter, compared to $0.77 in the year-ago quarter. The current stock performance of Otis Worldwide shows a 52-week-high of $88.22 and a 52-week-low of $62.49. Moreover, at the end of the last trading period, the closing price was at $78.09.

Exane BNP Paribas downgraded the previous rating for Thomson Reuters Corp TRI from Neutral to Underperform. Thomson Reuters earned $0.57 in the third quarter, compared to $0.46 in the year-ago quarter. The stock has a 52-week-high of $122.25 and a 52-week-low of $91.55. At the end of the last trading period, Thomson Reuters closed at $117.72.

For PagSeguro Digital Ltd PAGS, Goldman Sachs downgraded the previous rating of Neutral to Sell. For the third quarter, PagSeguro Digital had an EPS of $0.24, compared to year-ago quarter EPS of $0.24. At the moment, the stock has a 52-week-high of $29.28 and a 52-week-low of $9.45. PagSeguro Digital closed at $10.53 at the end of the last trading period.

According to Chardan Capital, the prior rating for Oncorus Inc ONCR was changed from Buy to Neutral. Oncorus earned $0.76 in the third quarter, compared to $0.65 in the year-ago quarter. The current stock performance of Oncorus shows a 52-week-high of $6.08 and a 52-week-low of $0.41. Moreover, at the end of the last trading period, the closing price was at $0.48.

See all analyst ratings downgrades.

Initiations

Redburn Partners initiated coverage on Palo Alto Networks Inc PANW with a Buy rating. The price target for Palo Alto Networks is set to $270.00. In the first quarter, Palo Alto Networks showed an EPS of $0.83, compared to $0.55 from the year-ago quarter. The current stock performance of Palo Alto Networks shows a 52-week-high of $213.63 and a 52-week-low of $140.07. Moreover, at the end of the last trading period, the closing price was at $169.90.

With a Buy rating, Redburn Partners initiated coverage on CrowdStrike Holdings Inc CRWD. The price target seems to have been set at $175.00 for CrowdStrike Holdings. In the third quarter, CrowdStrike Holdings showed an EPS of $0.40, compared to $0.17 from the year-ago quarter. The current stock performance of CrowdStrike Holdings shows a 52-week-high of $242.00 and a 52-week-low of $108.89. Moreover, at the end of the last trading period, the closing price was at $117.65.

Redburn Partners initiated coverage on SentinelOne Inc S with a Neutral rating. The price target for SentinelOne is set to $18.00. In the second quarter, SentinelOne showed an EPS of $0.20, compared to $0.38 from the year-ago quarter. The stock has a 52-week-high of $59.54 and a 52-week-low of $13.27. At the end of the last trading period, SentinelOne closed at $14.50.

With a Neutral rating, Redburn Partners initiated coverage on Zscaler Inc ZS. The price target seems to have been set at $135.00 for Zscaler. The stock has a 52-week-high of $373.74 and a 52-week-low of $114.21. At the end of the last trading period, Zscaler closed at $133.45.

Zelman & Assoc initiated coverage on Ferguson PLC FERG with a Buy rating. In the fourth quarter, Ferguson showed an EPS of $2.85, compared to $2.37 from the year-ago quarter. The stock has a 52-week-high of $183.67 and a 52-week-low of $99.16. At the end of the last trading period, Ferguson closed at $117.23.

Jefferies initiated coverage on Full Truck Alliance Co Ltd YMM with a Buy rating. The price target for Full Truck Alliance Co is set to $11.00. Full Truck Alliance Co earned $0.07 in the third quarter, compared to $0.00 in the year-ago quarter. At the moment, the stock has a 52-week-high of $13.28 and a 52-week-low of $4.12. Full Truck Alliance Co closed at $8.53 at the end of the last trading period.

With a Buy rating, New Street Research initiated coverage on Mobileye Global Inc MBLY. The price target seems to have been set at $42.00 for Mobileye Global. In the first quarter, Mobileye Global showed an EPS of $0.25, compared to $0.15 from the year-ago quarter. The stock has a 52-week-high of $31.88 and a 52-week-low of $24.85. At the end of the last trading period, Mobileye Global closed at $28.51.

New Street Research initiated coverage on Coupang Inc CPNG with a Buy rating. The price target for Coupang is set to $25.00. Coupang earned $0.05 in the third quarter, compared to $0.19 in the year-ago quarter. The current stock performance of Coupang shows a 52-week-high of $30.65 and a 52-week-low of $8.98. Moreover, at the end of the last trading period, the closing price was at $19.48.

Janney Montgomery Scott initiated coverage on Sunnova Energy International Inc NOVA with a Buy rating. The price target for Sunnova Energy Intl is set to $33.00. For the third quarter, Sunnova Energy Intl had an EPS of $0.54, compared to year-ago quarter EPS of $0.25. The stock has a 52-week-high of $38.56 and a 52-week-low of $12.47. At the end of the last trading period, Sunnova Energy Intl closed at $22.83.

Janney Montgomery Scott initiated coverage on Sunrun Inc RUN with a Neutral rating. The price target for Sunrun is set to $30.00. Sunrun earned $0.96 in the third quarter, compared to $0.11 in the year-ago quarter. At the moment, the stock has a 52-week-high of $48.02 and a 52-week-low of $16.80. Sunrun closed at $32.58 at the end of the last trading period.

With a Neutral rating, UBS initiated coverage on TriplePoint Venture Growth BDC Corp TPVG. The price target seems to have been set at $13.50 for TriplePoint Venture Gwth. In the third quarter, TriplePoint Venture Gwth showed an EPS of $0.51, compared to $0.32 from the year-ago quarter. The stock has a 52-week-high of $18.31 and a 52-week-low of $10.41. At the end of the last trading period, TriplePoint Venture Gwth closed at $12.94.

Citigroup initiated coverage on GoodRx Holdings Inc GDRX with a Buy rating. The price target for GoodRx Holdings is set to $7.00. For the third quarter, GoodRx Holdings had an EPS of $0.07, compared to year-ago quarter EPS of $0.09. At the moment, the stock has a 52-week-high of $42.87 and a 52-week-low of $3.82. GoodRx Holdings closed at $4.36 at the end of the last trading period.

With an Underweight rating, JP Morgan initiated coverage on Sapiens International Corp NV SPNS. The price target seems to have been set at $20.00 for Sapiens Intl Corp. For the third quarter, Sapiens Intl Corp had an EPS of $0.30, compared to year-ago quarter EPS of $0.31. At the moment, the stock has a 52-week-high of $36.61 and a 52-week-low of $16.18. Sapiens Intl Corp closed at $19.46 at the end of the last trading period.

B of A Securities initiated coverage on SpringWorks Therapeutics Inc SWTX with a Buy rating. The price target for SpringWorks Therapeutics is set to $45.00. For the third quarter, SpringWorks Therapeutics had an EPS of $1.37, compared to year-ago quarter EPS of $0.84. At the moment, the stock has a 52-week-high of $74.97 and a 52-week-low of $13.60. SpringWorks Therapeutics closed at $24.18 at the end of the last trading period.

B of A Securities initiated coverage on Day One Biopharmaceuticals Inc DAWN with a Buy rating. The price target for Day One Biopharmaceutical is set to $34.00. For the third quarter, Day One Biopharmaceutical had an EPS of $0.53, compared to year-ago quarter EPS of $0.33. The current stock performance of Day One Biopharmaceutical shows a 52-week-high of $28.35 and a 52-week-low of $5.44. Moreover, at the end of the last trading period, the closing price was at $21.23.

With a Neutral rating, JP Morgan initiated coverage on Duck Creek Technologies Inc DCT. The price target seems to have been set at $13.00 for Duck Creek Technologies. Duck Creek Technologies earned $0.03 in the fourth quarter, compared to $0.02 in the year-ago quarter. The current stock performance of Duck Creek Technologies shows a 52-week-high of $32.49 and a 52-week-low of $10.04. Moreover, at the end of the last trading period, the closing price was at $11.19.

With an Outperform rating, Cowen & Co. initiated coverage on scPharmaceuticals Inc SCPH. The price target seems to have been set at $25.00 for scPharmaceuticals. scPharmaceuticals earned $0.37 in the third quarter, compared to $0.24 in the year-ago quarter. The current stock performance of scPharmaceuticals shows a 52-week-high of $7.96 and a 52-week-low of $3.48. Moreover, at the end of the last trading period, the closing price was at $7.33.

JP Morgan initiated coverage on Guidewire Software Inc GWRE with an Overweight rating. The price target for Guidewire Software is set to $78.00. For the fourth quarter, Guidewire Software had an EPS of $0.03, compared to year-ago quarter EPS of $0.37. The current stock performance of Guidewire Software shows a 52-week-high of $119.46 and a 52-week-low of $52.08. Moreover, at the end of the last trading period, the closing price was at $59.31.

With a Equal-Weight rating, Morgan Stanley initiated coverage on VIZIO Holding Corp VZIO. The price target seems to have been set at $13.00 for VIZIO Holding. For the third quarter, VIZIO Holding had an EPS of $0.01, compared to year-ago quarter EPS of $0.10. The stock has a 52-week-high of $20.98 and a 52-week-low of $6.47. At the end of the last trading period, VIZIO Holding closed at $10.29.

Deutsche Bank initiated coverage on NeoGames SA NGMS with a Buy rating. The price target for NeoGames is set to $17.00. In the third quarter, NeoGames showed an EPS of $0.10, compared to $0.06 from the year-ago quarter. The current stock performance of NeoGames shows a 52-week-high of $34.82 and a 52-week-low of $10.69. Moreover, at the end of the last trading period, the closing price was at $13.81.

With a Buy rating, HC Wainwright & Co. initiated coverage on Viridian Therapeutics Inc VRDN. The price target seems to have been set at $35.00 for Viridian Therapeutics. In the third quarter, Viridian Therapeutics showed an EPS of $0.86, compared to $1.25 from the year-ago quarter. The stock has a 52-week-high of $27.08 and a 52-week-low of $9.47. At the end of the last trading period, Viridian Therapeutics closed at $25.27.

With a Buy rating, Goldman Sachs initiated coverage on Altimmune Inc ALT. The price target seems to have been set at $20.00 for Altimmune. In the third quarter, Altimmune showed an EPS of $0.48, compared to $0.81 from the year-ago quarter. The current stock performance of Altimmune shows a 52-week-high of $23.49 and a 52-week-low of $3.83. Moreover, at the end of the last trading period, the closing price was at $9.95.

Goldman Sachs initiated coverage on Aclaris Therapeutics Inc ACRS with a Buy rating. The price target for Aclaris Therapeutics is set to $25.00. In the third quarter, Aclaris Therapeutics showed an EPS of $0.30, compared to $0.35 from the year-ago quarter. The current stock performance of Aclaris Therapeutics shows a 52-week-high of $18.96 and a 52-week-low of $9.26. Moreover, at the end of the last trading period, the closing price was at $15.22.

With a Buy rating, Goldman Sachs initiated coverage on RAPT Therapeutics Inc RAPT. The price target seems to have been set at $27.00 for RAPT Therapeutics. For the third quarter, RAPT Therapeutics had an EPS of $0.63, compared to year-ago quarter EPS of $0.63. The stock has a 52-week-high of $40.74 and a 52-week-low of $9.86. At the end of the last trading period, RAPT Therapeutics closed at $17.68.

With a Buy rating, JonesTrading initiated coverage on Dare Bioscience Inc DARE. The price target seems to have been set at $6.00 for Dare Bioscience. For the third quarter, Dare Bioscience had an EPS of $0.08, compared to year-ago quarter EPS of $0.18. The stock has a 52-week-high of $2.51 and a 52-week-low of $0.88. At the end of the last trading period, Dare Bioscience closed at $0.89.

Janney Montgomery Scott initiated coverage on WSFS Financial Corp WSFS with a Buy rating. The price target for WSFS Financial is set to $57.00. For the third quarter, WSFS Financial had an EPS of $1.23, compared to year-ago quarter EPS of $1.19. The stock has a 52-week-high of $56.30 and a 52-week-low of $37.03. At the end of the last trading period, WSFS Financial closed at $48.51.

See all analyst ratings initiations.